Literature DB >> 1581314

Free fatty acids activate a high-affinity saturable pathway for degradation of low-density lipoproteins in fibroblasts from a subject homozygous for familial hypercholesterolemia.

B E Bihain1, F T Yen.   

Abstract

This paper describes a mechanism for degradation of low-density lipoprotein (LDL) in fibroblasts unable to synthesize the LDL receptor. In this cell line, long-chain free fatty acids (FFA) activated 125I-LDL uptake; unsaturated FFA were the most efficient. The first step of this pathway was the binding of LDL apoB to a single class of sites on the plasma membrane and was reversible in the presence of greater than or equal to 10 mM suramin. Binding equilibrium was achieved after a 60-90-min incubation at 37 degrees C with 1 mM oleate; under these conditions, the apparent Kd for 125I-LDL binding was 12.3 micrograms/mL. Both cholesterol-rich (LDL and beta-VLDL) and triglyceride-rich (VLDL) lipoproteins, but not apoE-free HDL, efficiently competed with 125I-LDL for this FFA-induced binding site. After LDL bound to the cell surface, they were internalized and delivered to lysosomes; chloroquine inhibited subsequent proteolysis of LDL and thereby increased the cellular content of the particles. A physiological oleate to albumin molar ratio, i.e., 1:1 (25 microM oleate and 2 mg/mL albumin), was sufficient to significantly (p less than 0.01) activate all three steps of this alternate pathway: for example, 644 +/- 217 (25 microM oleate) versus 33 +/- 57 (no oleate) ng of LDL/mg of cell protein was degraded after incubation (2 h, 37 degrees C) with 50 micrograms/mL 125I-LDL. We speculate that this pathway could contribute to the clearance of both chylomicron remnants and LDL.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1581314     DOI: 10.1021/bi00134a013

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  10 in total

1.  Familial hypercholesterolaemia.

Authors:  A David Marais
Journal:  Clin Biochem Rev       Date:  2004-02

2.  Nuclear Localized LSR: A Novel Regulator of Breast Cancer Behavior and Tumorigenesis.

Authors:  Denise K Reaves; Katherine A Hoadley; Katerina D Fagan-Solis; Dereje D Jima; Michael Bereman; Lynnelle Thorpe; Jyla Hicks; David McDonald; Melissa A Troester; Charles M Perou; Jodie M Fleming
Journal:  Mol Cancer Res       Date:  2016-11-17       Impact factor: 5.852

3.  Effect of reduced low-density lipoprotein receptor level on HepG2 cell cholesterol metabolism.

Authors:  L Izem; E Rassart; L Kamate; L Falstrault; D Rhainds; L Brissette
Journal:  Biochem J       Date:  1998-01-01       Impact factor: 3.857

4.  Hepatic lipase may act as a ligand in the uptake of artificial chylomicron remnant-like particles by isolated rat hepatocytes.

Authors:  P Diard; M I Malewiak; D Lagrange; S Griglio
Journal:  Biochem J       Date:  1994-05-01       Impact factor: 3.857

5.  Immunoglobulin-like domain containing receptor 1 mediates fat-stimulated cholecystokinin secretion.

Authors:  Rashmi Chandra; Yu Wang; Rafiq A Shahid; Steven R Vigna; Neil J Freedman; Rodger A Liddle
Journal:  J Clin Invest       Date:  2013-07-25       Impact factor: 14.808

6.  Recognition of lactoferrin and aminopeptidase M-modified lactoferrin by the liver: involvement of proteoglycans and the remnant receptor.

Authors:  G J Ziere; J K Kruijt; M K Bijsterbosch; T J van Berkel
Journal:  Biochem J       Date:  1996-01-01       Impact factor: 3.857

7.  Evidence for linkage of the apolipoprotein A-II locus to plasma apolipoprotein A-II and free fatty acid levels in mice and humans.

Authors:  C H Warden; A Daluiski; X Bu; D A Purcell-Huynh; C De Meester; B H Shieh; D L Puppione; R M Gray; G M Reaven; Y D Chen
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-15       Impact factor: 11.205

8.  Increased cell motility and invasion upon knockdown of lipolysis stimulated lipoprotein receptor (LSR) in SW780 bladder cancer cells.

Authors:  Malene Herbsleb; Karin Birkenkamp-Demtroder; Thomas Thykjaer; Carsten Wiuf; Anne-Mette K Hein; Torben F Orntoft; Lars Dyrskjøt
Journal:  BMC Med Genomics       Date:  2008-07-22       Impact factor: 3.063

9.  Liver-specific loss of lipolysis-stimulated lipoprotein receptor triggers systemic hyperlipidemia in mice.

Authors:  Prachiti Narvekar; Mauricio Berriel Diaz; Anja Krones-Herzig; Ulrike Hardeland; Daniela Strzoda; Sigrid Stöhr; Marcus Frohme; Stephan Herzig
Journal:  Diabetes       Date:  2009-02-02       Impact factor: 9.461

10.  Inhibitory action of benzo[α]pyrene on hepatic lipoprotein receptors in vitro and on liver lipid homeostasis in mice.

Authors:  Hamed Layeghkhavidaki; Marie-Claire Lanhers; Samina Akbar; Lynn Gregory-Pauron; Thierry Oster; Nathalie Grova; Brice Appenzeller; Jordane Jasniewski; Cyril Feidt; Catherine Corbier; Frances T Yen
Journal:  PLoS One       Date:  2014-07-23       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.